 HONG KONG, SHANGHAI and FLORHAM PARK, N.J., Jan. 14, 2021 GLOBE NEWSWIRE -- Hutchison China MediTech Limited Chi-Med NasdaqAIM: HCM today announces that the final analysis of savolitinib in Phase Ib TATTON study Parts B and D will be presented at the upcoming virtual 2020 World Conference on Lung Cancer WCLC 2020, taking place on January 28-31, 2021, virtually. 